Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cholangiocarcinoma × Clinical Protocols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4 Paraproteinemias 2 Immunoglobulin Light-chain Amyloidosis 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Pneumonia 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Locally Advanced Breast Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Gemcitabine 94 Cisplatin 62 Oxaliplatin 38 pembrolizumab 29 Fluorouracil 28 Capecitabine 27 durvalumab 24 Leucovorin 22 lenvatinib 21 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 pemigatinib 9 apatinib 9 Radiotherapy 9 Radiofrequency Ablation 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 8 Specimen Handling 8 Floxuridine 8 Bevacizumab 8 Folfox protocol 7 Carboplatin 7 Biopsy 7 tremelimumab 6 sintilimab 6 atezolizumab 6 Photochemotherapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05557578 2025-02-11

GOT

Zhejiang Cancer Hospital

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡